Opens in a new tab

EOFlow v Insulet (CoA, 29 January 2026)

Date29 January 2026
CourtCoA
DivisionLuxembourg (LU)
Type of actionApplication RoP262.2
Case number(s)UPC_CoA_930/2025
Registry referenceUPC-COA-0000930/2025
PartiesEOFlow Co., Ltd. v. Insulet Corporation

Official decision (PDF) · UPC registry entry

Case timeline

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

In EOFlow Co., Ltd.’s appeal against the order of the Milan Central Division of 4 December 2025 (penalty payments imposed in favour of Insulet Corporation, EP 4 201 327), the Court of Appeal orders that the documents lodged by EOFlow as “confidential” be made available to Insulet and its representatives, and refuses to restrict Insulet’s use of the distribution information communicated in compliance with a court order.

Question

Is information communicated in compliance with an order under Art. 67 UPCA implicitly subject to a restriction on use in favour of the party providing it, and may a party lodge documents under the “HC” code without an application under Rule 262A RoP?

Decision

Granting a request under Rule 262.2 RoP does not protect against disclosure to the other party. Only a Rule 262A RoP application does (paragraph 24). There is no implicit limitation on the use of information received as a result of compliance with an order under Art. 67 UPCA and Rule 191 RoP, Rule 262A RoP applies at least mutatis mutandis, and EOFlow, which stated that it would not file such an application, should have done so (paragraphs 25 and 26). Information communicated without restriction is in any event no longer confidential (paragraph 27). Lodging documents under the “HC” code without a simultaneous Rule 262A RoP application has no legal basis (paragraph 29). The remaining requests (register, redaction of decisions, exclusion of the public) will be decided later (paragraph 30).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts 58 and 67
Rules of Procedure
Rules 115, 190.1, 191, 262.1(b), 262.2 and 262A
Case law cited
Kodak v Fujifilm, Court of Appeal, 14 October 2025 (UPC_CoA_699/2025), Strabag v Swarco Futurit, Court of Appeal, 1 August 2025, UPC_CoA_70/2025, Merz v Viatris, Court of Appeal, 26 January 2026 (UPC_CoA_917/2025), Insulet v A. Menarini, Court of Appeal, 9 January 2025 (UPC_CoA_769/2024, dated 9 January 2024 in the order).

Related decisions

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Decisions in the same proceedings

Going further

Lexicon: UPC Court of Appeal, Supplementary protection certificate (SPC), Biosimilar medicinal product, Launch at risk.

Dhenne Avocats blog: UPC Appeals: What the Numbers Show, Pharmaceutical patents and the UPC: is the Court hostile to them?.

Publications by Matthieu Dhenne: The Launch Letter: How Generics and Biosimilars Should Write to Avoid UPC Urgency (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CoA_930/2025 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

  1. 29 January 2026 EOFlow v Insulet (CoA, 29 January 2026) Application RoP262.2 · UPC_CoA_930/2025
  2. 4 February 2026 EOFlow v Insulet (CoA, 4 February 2026) Appeal RoP220.2 · UPC_CoA_930/2025 · appeal, first-instance number cited in the decision

    L’appel contre l’ordonnance prononçant une astreinte et fixant les frais est irrecevable faute d’autorisation expresse de la division de première instance. La demande d’effet suspensif est rejetée.

  3. 18 March 2026 EOFLOW v Insulet (CoA, 18 March 2026) Appeal RoP220.2 · UPC_CoA_930/2025 · appeal, first-instance number cited in the decision

    La cour d'appel rejette l'appel d'EOFlow : les informations communiquées à Insulet sans ordonnance au titre de la règle 262A ne sont plus des secrets d'affaires ni des informations confidentielles, aucune limitation implicite d'usage n'existant.

What the record states

Nature of the act
Application RoP262.2
Outcome (Dhenne Avocats summary)
Les pièces déposées comme confidentielles sont rendues accessibles à l’autre partie et la demande de restriction d’usage est rejetée : les informations communiquées en exécution d’une injonction ne sont protégées que par une demande au titre de la règle 262A.
Appeal
Decision of the Court of Appeal.
Instance
Court of Appeal decision.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 4 201 327
Fluid delivery device with transcutaneous access tool, insertion mechanism and blood glucose monitoring for use therewith
recorded proprietor: Insulet Corp
Mentioned in the analysis (role not qualified)
Also mentioned in 25 other decision(s): EOFLOW v Insulet (CFI, 22 July 2025) · EOFLOW v Insulet (CoA, 18 March 2026) · EOFlow v Insulet (CoA, 26 February 2026) · EOFlow v Insulet (CoA, 4 February 2026) · Herbert Smith Freehills Kramer (applicant) in Insulet v EOFLow (CoA, 2 · Insulet v EOFLOW (CFI, 15 October 2025) · EOFLOW v Insulet (CFI, ORD_26828/2025, 5 June 2025) · EOFLOW v Insulet (CFI, 28 May 2025)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.